A compound of formal (I) is described: wherein R1 and R2 are as defined in the text and wherein the compounds are intended for use in treating medical conditions characterized by an imbalance in dopamine receptor activity.
申请公布号
ES2603880(T3)
申请公布日期
2017.03.01
申请号
ES20080845853T
申请日期
2008.10.28
申请人
MOTAC NEUROSCIENCE LIMITED
发明人
STARK, Holger;LEPPANEN, Jukka;SASSE, Britta;SAUR, Oliver;KOTTKE, Tim;HILL, Michael
